Vitality Watch

Dossier pubmed observational 22-sep-2026
Human cohort, case-control, or epidemiological association

Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.

Key claim: Tissue-specific transcriptomic aging clocks reveal that most compounds show mixed age-modulatory score directions across human tissues and cell categories, with only a small fraction showing strong bidirectional divergence, and rapamycin scoring net pro-aging transcriptionally in this system.

Abstract

Aging clocks are typically trained on pooled multi-tissue data, implicitly assuming that aging is uniform across organs. Here we challenge this assumption by constructing 49 transcriptomic clocks across 47 tissue types and 2 cell-line categories from GTEx v8 (948 unique donors contributing to the retained clock categories) using donor-grouped cross-validation. Clocks achieved a median Pearson r of 0.543 (best: artery aorta, r = 0.855). We identified 10,253 unique clock genes, of which 69.2% appeared in only one tissue; however, null simulation confirmed that this low overlap is the expected consequence of sparse elastic-net selection rather than biological tissue-specificity. We then projected 3,926 LINCS L1000 compound-name entries onto each clock to build a drug × category age-reversal matrix. At a permissive threshold (|score|> 1.0), 94.2% of drugs showed mixed score directions (positive in some categories and negative in others). This permissive mixed-direction proportion was descriptive and did not itself exceed shuffled expectations. Under a more stringent exploratory criterion requiring |score|> 2.0 in at least three categories in each direction, 2.8% of compound entries showed pronounced bidirectional divergence, compared with approximately 0.1% under the shuffled null. Compound rankings remained stable when analysis was restricted to the 34 clocks with r ≥ 0.5 (Spearman ρ = 0.897 versus the full analysis). A Jaccard-based enrichment statistic yielded highly concordant compound rankings (median per-category Spearman ρ = 0.961), indicating that results were not artifacts of the enrichment method. After Benjamini-Hochberg FDR correction across all 192,374 drug-category pairs, only 0.79% reached FDR < 0.05, indicating that individual drug-category calls require caution. Rapamycin showed net pro-aging transcriptional signatures in our system; we explicitly emphasize that transcriptome-based scores and organismal lifespan are distinct endpoints. DepMap CRISPR analysis was repeated after GTEx-based standardization across 13 matched categories, although individual gene-level results were limited. Four statistical robustness tests confirmed model stability. These findings describe category-associated drug-score patterns and provide a tissue-aware resource for generating hypotheses about drug responses, while cautioning against over-interpretation of individual drug-category predictions without experimental validation.

Why this matters

Multi-tissue transcriptomic clocks make explicit what single-tissue clocks obscure: a drug can score anti-aging in one tissue and pro-aging in another, so any headline claim about a compound ‘reversing biological age’ collapses a matrix into a scalar. The rapamycin call — net pro-aging transcriptionally in this system — is the kind of dissonant signal that this area exists to flag, because it sits against animal lifespan data and epigenetic-clock movement claims and forces the question of which readout is actually tracking aging. As a resource, it strengthens the argument that clock movement is a modality-dependent statistical output, not a measurement of aging itself.

Source

Link

Briefing card

Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.
Stage: observational · pubmed · 22-sep-2026

If you follow biological-age claims for specific drugs (including rapamycin), this resource shows those claims can flip sign depending on which tissue's transcriptomic clock you read.

Tissue-specific transcriptomic aging clocks reveal that most compounds show mixed age-modulatory score directions across human tissues and cell categories, with only a small fraction showing strong bidirectional divergence, and rapamycin scoring net pro-aging transcriptionally in this system.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s10522-026-10512-2

build build 880 · 2bcef25 · 2026-11-18